Vanguard Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Sell |
|
|||||
|
2025
Q1 | $4.26M | Buy |
|
|||||
|
2024
Q4 | $4.88M | Sell |
|
|||||
|
2024
Q3 | $5.73M | Sell |
|
|||||
|
2024
Q2 | $4.55M | Sell |
|
|||||
|
2024
Q1 | $5.21M | Buy |
|
|||||
|
2023
Q4 | $8.41M | Buy |
|
|||||
|
2023
Q3 | $13M | Buy |
|
|||||
|
2023
Q2 | $25.7M | Sell |
|
|||||
|
2023
Q1 | $33.2M | Sell |
|
|||||
|
2022
Q4 | $34.1M | Sell |
|
|||||
|
2022
Q3 | $42.4M | Buy |
|
|||||
|
2022
Q2 | $18.3M | Buy |
|
|||||
|
2022
Q1 | $36.1M | Buy |
|
|||||
|
2021
Q4 | $39M | Buy |
|
|||||
|
2021
Q3 | $27.5M | Buy |
|
|||||
|
2021
Q2 | $81.2M | Sell |
|
|||||
|
2021
Q1 | $70.4M | Buy |
|
|||||
|
2020
Q4 | $77.6M | Buy |
|
|||||
|
2020
Q3 | $78M | Buy |
|
|||||
|
2020
Q2 | $10.7M | Buy |
|
|||||
|
2020
Q1 | $7.69M | Buy |
|
|||||
|
2019
Q4 | $7.38M | Buy |
|
|||||
|
2019
Q3 | $8.39M | Buy |
|
|||||
|
2019
Q2 | $6.63M | Buy |
|
|||||
|
2019
Q1 | $6.19M | Buy |
|
|||||
|
2018
Q4 | $3.85M | Sell |
|
|||||
|
2018
Q3 | $7.82M | Sell |
|
|||||
|
2018
Q2 | $12.2M | Sell |
|
|||||
|
2018
Q1 | $12.6M | Buy |
|
|||||
|
2017
Q4 | $15.8M | Sell |
|
|||||
|
2017
Q3 | $26.7M | Buy |
|
|||||
|
2017
Q2 | $17.9M | Buy |
|
|||||
|
2017
Q1 | $17.6M | Buy |
|
|||||
|
2016
Q4 | $14.5M | Buy |
|
|||||
|
2016
Q3 | $16.6M | Buy |
|
|||||
|
2016
Q2 | $34.2M | Buy |
|
|||||
|
2016
Q1 | $25.2M | Buy |
|
|||||
|
2015
Q4 | $19.1M | Buy |
|
|||||
|
2015
Q3 | $14.2M | Buy |
|
|||||
|
2015
Q2 | $830K | Buy |
|